Maxim Group Downgrades Processa Pharmaceuticals (PCSA) to Hold
Tweet
Share
E-mailGet Alerts PCSA Hot Sheet
Price: $2.43 -2.8%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Maxim Group analyst Naz Rahman downgraded Processa Pharmaceuticals (NASDAQ: PCSA) from Buy to Hold.
For an analyst ratings summary and ratings history on Processa Pharmaceuticals click here. For more ratings news on Processa Pharmaceuticals click here.
Shares of Processa Pharmaceuticals closed at $0.42 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- RBC Capital Downgrades CareTrust REIT (CTRE) to Sector Perform
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
